Dr Lal Path Labs, India's largest diagnostics firm by revenue, reported a strong fourth-quarter performance for fiscal year 2025, with net profit rising 81.2% year-on-year to Rs 156 crore and revenue increasing 10.5% to Rs 603 crore. The company also saw a 16.8% increase in EBITDA to Rs 169 crore and an EBITDA margin expansion to 28%, outperforming CNBC-TV18's estimates. In contrast, RBL Bank's Q4 results showed an 80% drop in net profit to Rs 69 crore due to higher provisions, despite increased other income, and the bank's board declared a dividend. Chola Fin is expected to announce healthy asset under management (AUM) and profit growth in its Q4 earnings. Meanwhile, Lloyds Metals and Energy Ltd. reported a weak quarter with revenue down 22.4% year-on-year to Rs 1,212.6 crore, EBITDA falling 39.9% to Rs 280.4 crore, and net profit declining 27.1% to Rs 201.9 crore.